The monkeys were assigned to seven groups ( n = 10 monkeys per group) with equal distribution of blood chemistries and BW
While the concept of GLP-1 microdosing is still being explored, the mechanism of GLP-1 drugs suggests how this dosing strategy might address common metabolic issues, and improve: Weight management and appetite control Energy consistency and fatigue reduction Insulin sensitivity While there are no primary clinical trials specifically designed to prove the long-term effectiveness of GLP-1 medication microdosing, the efficacy of low doses has been demonstrated within the full clinical trial data on dose-response relationships and titration phases: A years-long study of 2,405 patients that helped establish the efficacy of the current highest approved dose of semaglutide for weight loss found that lower doses still showed significant weight loss and appetite suppression compared to placebo
2015;115(11):1861-1870.) The best fiber sources for semaglutide and other GLP-1 users: Non-starchy vegetables broccoli, Brussels sprouts, carrots, leafy greens like spinach, kale, and Swiss chard Whole grains oats, quinoa, and brown rice provide sustained energy and steady blood sugar Legumes their fiber-protein combination is nearly unmatched for GLP-1 users Low-sugar fruits berries (blueberries, strawberries, raspberries) offer antioxidants and fiber with less sugar impact than most other fruits If you're new to GLP-1 medications, increase fiber gradually
These extended timelines reflect the substantial investment pharmaceutical companies make in drug development and clinical trials
